Eton Pharmaceuticals, Inc.
ETON · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,823 | -$936 | -$9,021 | -$1,955 |
| Dep. & Amort. | $1,146 | $901 | $1,774 | $462 |
| Deferred Tax | $0 | $0 | $0 | -$546 |
| Stock-Based Comp. | $3,165 | $3,137 | $4,218 | $3,381 |
| Change in WC | -$698 | $3,529 | $7,661 | -$6,211 |
| Other Non-Cash | $1,179 | $184 | $189 | $148 |
| Operating Cash Flow | $969 | $6,815 | $4,821 | -$4,721 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$26 | -$775 | -$38 | -$3,259 |
| Net Acquisitions | -$30,000 | $0 | $0 | $700 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$9,988 | $0 | -$2,750 | $0 |
| Investing Cash Flow | -$40,014 | -$775 | -$2,788 | -$2,559 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $24,154 | -$1,155 | -$385 | -$150 |
| Stock Issued | $8,191 | $0 | $0 | $541 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $248 | $198 | $251 | $0 |
| Financing Cash Flow | $32,593 | -$957 | -$134 | $391 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6,452 | $5,083 | $1,899 | -$6,889 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,388 | $16,305 | $14,406 | $21,295 |
| End Cash | $14,936 | $21,388 | $16,305 | $14,406 |
| Free Cash Flow | $943 | $6,040 | $2,033 | -$7,980 |